Skip to main content

Table 2 Effect of pre-treatment with drugs or cytokines on the magnitude of Human ASM IPx signalling responses following histamine, bradykinin or sodium fluoride stimulation.

From: Salmeterol and cytokines modulate inositol-phosphate signalling in Human airway smooth muscle cells via regulation at the receptor locus

Cytokine/drug

Histamine response

Bradykinin response

NaF response

IL-1β

97.0 (+/- 4.1)

97.8 (+/- 4.3)

85.9 (+/- 8.1)

TNFα

113.0 (+/- 8.4)

127.4 (+/- 8.3) +**

102.8 (+/- 11.9)

IL-13

144.3 (+/- 9.3) +**

113.8 (+/- 7.0)

124.2 (+/- 15.6)

IFNγ

126.4 (+/- 7.5) **

128.0 (+/- 8.4) +**

132.3 (+/- 14.0)

Salmeterol

117.7 (+/- 5.2) **

111.7 (+/- 5.0) *

116.2 (+/- 10.9)

Dexamethasone

105.6 (+/- 4.4)

100.3 (+/- 5.0)

113.2 (+/- 10.4)

  1. ASM cells were serum starved for 24 hours and then treated with medium alone, 10 ng/ml IL-1β, 10 ng/ml TNFα, 10 ng/ml IFNγ, 50 ng/ml IL-13, 1 μM dexamethasone or 1 μM salmeterol for 24 hours. Cells were loaded with [3H]-myo-inositol and IPx production following 100 μM Histamine, 0.1 μM bradykinin or 10 mM Sodium Fluoride stimulation was determined as described [30]. The IPx production in the medium alone treated cells was normalised to 100% and the other treatment groups determined relative to this. Data represents the mean response +/- S.E.M, n = 9 (three independent experiments for 3 donors). Data within groups was compared by ANOVA and post hoc Dunnett's Multiple Copmarison Test (+p < 0.05) or T-Test (*p < 0.05, **p < 0.01).